Chong-xian Pan, MD, PhD

​Brigham and Women's Hospital– Boston, Massachusetts

Chong-xian Pan, MD, PhD, MS, is an Associate Professor of Medicine at Brigham and Women’s Hospital and Harvard Medical School.

Dr. Pan is a medical oncologist, physician-scientist, and clinical investigator. His lab mainly focuses on translational research in bladder cancer, including drug development, patient-derived cancer models and immunotherapy. He has successfully translated his own preclinical studies into six investigator-initiated clinical trials, including organizing three GMP (Good Manufacturing Practice) formulations and IND (Investigational New Drug) applications.

Dr. Pan earned his medical degree at Fudan University Shanghai Medical College, Shanghai, China, a PhD in Microbiology and Immunology at Loyola University of Chicago and an MS in Clinical Research at the University of California Davis. His post-graduate training included a four-year residency of Urology in China, residency of Internal Medicine at Saint Francis hospital, and a fellowship of Hematology and Medical Oncology at Indiana University.

Dr. Pan has received numerous awards including the NCI Cancer Clinical Investigator Team Leadership Award. His research has been funded by the Veteran Administration Merit Award, NIH, DoD, American Cancer Society, California Institute for Regenerative Medicine and others.